Lutronic eCO2 Plus Laser
Lutronic eCO2 Plus Laser Plus Laser Dual Mode CO2 Resurfacing Laser. The Lutronic eCO2 Plus is the leading fractional and ablative laser. The eCO2 works with the patented Controlled Chaos Technology (CCTTM), an algorithm that delivers each micro-laser beam pseudo-randomly so that there is a maximum distance between the successive beams. This enables the tissue to dissipate the greatest possible amount of heat between the shots. As a result, this means increased safety, fewer post-operative discomfort and a faster healing process with unparalleled results in partial skin renewal treatments.
Lutronic eCO2 Plus has the features you need to address a broad range of clinical conditions. The ultra-fast quick-change tips come in a choice of three spot sizes, 120, 300 and 500 μm, allowing you on-the-fly customized treatments. The eCO2’s tip auto-recognition feature automatically changes treatment settings to adjust for the change in spot size. The Dynamic Mode provides clinicians with a more comfortable operation by allowing the user to ‘Air Brush’ the energy. Static Mode allows for traditional ‘Stamping’ which allows users to treat scanned areas of 14 x 14 mm with selectable density options to enable precise delivery of laser energy without the need for multiple passes other systems require.
INDICATIONS
Skin Tightening
Wrinkles, Rhytids & Fine Lines
Pigmented Lesions & Lentigines
Scars (acne scar, surgical scar, burn scar)
Textural Irregularities
Trans epidermal Drug Delivery
Dyschromia
Solar/Actinic Elastosis
Vaporization, Incision & Excision Capabilities
Coagulation
Warts
MINIMAL DOWNTIME, IMPROVED COMFORT, INCREASED RELIABILITY
The eCO2 features a Controlled Chaos Technology (CCT), which generates random energy delivery patterns; This results in increased safety, reduced post-operative discomfort and faster healing time.
Key Benefits
– Easily and intuitively balance results and safety by delivering a full range of ablative/non-ablative energy at the desired energy and depth.
– With no artificial per-patient consumable and an extremely low cost of ownership, eCO2 owners can capture an extremely high percentage of treatment revenue.
There are no reviews yet.